Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20042715 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women
Condition: Epithelial Ovarian Cancer
Interventions: Procedure: CA125 assay on Abbott Architect i1000SR platform;   Procedure: HE4 assay on Architect i1000SR platform;   Procedure: Transvaginal Ultrasound

Indicates status has not been verified in more than two years